kairoby Opportune Labs

GHRP-6

GHRP-6 is a synthetic GH-releasing hexapeptide. Its effects extend beyond growth hormone to other endocrine systems, which matters when interpreting sleep and recovery claims.

Investigational / researchSmall human physiology studies
Kairo editorial · Sources reviewed September 9, 20264 sources
On this page
  1. Overview
  2. What the evidence shows
  3. Safety
  4. Common questions
  5. Questions for your clinician
  6. Sources

This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.

Overview

Product & regulatory status

Research peptide with limited clinical safety certainty.

Not GH-only signaling

The cited study measured ACTH and cortisol release as well as GH. Hormone pathways interact rather than operating as isolated switches. [1]

What the evidence shows

Sleep-laboratory study

A placebo comparison in healthy men measured overnight EEG and hormone profiles after intravenous GHRP-6. Investigators reported changes in sleep and GH secretion. [1]

A laboratory effect is not an insomnia treatment

The experiment studied a particular acute exposure in healthy controls. It does not establish durable sleep improvement, daytime function, or treatment of a diagnosed sleep disorder. [1]

What remains unknown

A beneficial sleep-stage measurement does not establish an overall benefit-risk balance, and evidence cannot be transferred automatically to other formulations.

Safety

Glucose and cortisol concerns

FDA identifies possible cortisol effects and reduced insulin sensitivity with higher glucose, alongside immune-response concerns for GHRP-6 preparations. [2]

Evidence applies to the studied route

The sleep experiment used intravenous administration. It does not establish a routine subcutaneous bedtime regimen. [1]

Understanding product quality

Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]

When to seek urgent help

Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]

A starting point for discussion

This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.

Common questions

Is it interchangeable with GHRP-2?

No. Similar names identify related compounds, not equivalent clinical effects or instructions.

Questions for your clinician

Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?

Sources

  1. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man1995 · Primary research · PubMed
  2. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksFDA · Compound-specific safety assessment
  3. Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
  4. AnaphylaxisMedlinePlus · recognizing an emergency

Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.